Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer

International Journal of Oncology

Volumn 39, Issue 2, 2011, Pages 373-381

  Singh, Rajesh ^a   Stockard, Cecil R ^b   Grizzle, William E ^b   Lillard Jr , James W ^a   Singh, Shailesh ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

CCR9 and CC125; Chemokine; Ovarian cancer

Indexed keywords

CHEMOKINE; CHEMOKINE CCL25; CHEMOKINE RECEPTOR CCR9; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; BRENNER TUMOR; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYSTADENOMA; DYSGERMINOMA; FIBROMA; FLOW CYTOMETRY; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MUCINOUS CARCINOMA; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; YOLK SAC TUMOR;

CELL LINE, TUMOR; CHEMOKINES, CC; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, CCR; TISSUE ARRAY ANALYSIS;

EID: 79960017581     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1059     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Liotta LA: An attractive force in metastasis. Nature 410: 24-25, 2001.
3. Nicolson GL: Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev 12: 325-343, 1993.
4. Zlotnik A and Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2000. (Pubitemid 30398626)
5. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001. (Pubitemid 32225831)
6. Wurbel MA, Malissen M, Guy-Grand D, et al: Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes. Blood 98: 2626-2632, 2001.
7. Zabel BA, Agace WW, Campbell JJ, et al: Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated Chemotaxis. J Exp Med 190: 1241-1256, 1999.
8. Kunkel EJ, Campbell JJ, Haraldsen G, et al: Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 192: 761-768, 2000.
9. + dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med 202: 1063-1073, 2005. (Pubitemid 41464500)
10. Autschbach F, Funke B, Katzenmeier M and Gassler N: Expression of chemokine receptors in normal and inflamed human intestine, tonsil, and liver - an immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigens. Cell Immunol 236: 110-114, 2005. (Pubitemid 41771094)
11. Papadakis KA, Prehn J, Moreno ST, et al: CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology 121: 246-254, 2001. (Pubitemid 32729371)
12. Singh S, Singh UP, Stiles JK, Grizzle WE and Lillard JW: Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin Cancer Res 10: 8743-8750, 2004. (Pubitemid 40053444)
13. Sharma PK, Singh R, Novakovic KR, Eaton JW, Grizzle WE and Singh S: CCR9-mediates PI3K/AKT dependent anti-apoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide. Int J Cancer 127: 2020-2030, 2010.
14. Cvetkovic D: Early events in ovarian oncogenesis. Reprod Biol Endocrinol 1: 68, 2003.
15. Strieter RM: Chemokines: Not just leukocyte chemoattractants in the promotion of cancer. Nat Immunol 2: 285, 2001.
16. Koenecke C and Forster R: CCR9 and inflammatory bowel disease. Expert Opin Ther Targets 13: 297-306, 2009.
17. Kabelitz D and Wesch D: Features and functions of gamma delta T lymphocytes: focus on chemokines and their receptors. Crit Rev Immunol 23: 339-370, 2003. (Pubitemid 38228400)
18. Hwang ST. Chemokine receptors in melanoma: CCR9 has a potential role in metastasis to the small bowel. J Invest Dermatol 122: xiv-xv, 2004.
19. Letsch A, Keilholz U, Schadendorf D, et al: Functional CCR9 expression is associated with small intestinal metastasis. J Invest Dermatol 122: 685-690, 2004. (Pubitemid 38471337)
20. Selvaggi SM: Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Arch Pathol Lab Med 124: 477, 2000.
21. Kurman RJ and Shih Ie M: The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34: 433-443, 2010.
22. Mora JR, Bono MR, Manjunath N, et al: Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424: 88-93, 2003. (Pubitemid 36834847)
23. Bell DA, Weinstock MA and Scully RE: Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer 62: 2212-2222, 1988.
24. Acs G: Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 123 (Suppl): S13-S57, 2005.
25. Tsuruchi N, Kaku T, Kinoshita H, et al: Ovarian mucinous cystadenocarcinoma with sarcoma-appearing mural nodule of anaplastic carcinoma. Gynecol Oncol 50: 259-263, 1993. (Pubitemid 23275216)
26. Malkasian GD Jr, Melton LJ, III, O'Brien PC and Greene MH: Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary. Am J Obstet Gynecol 149: 274-284, 1984.
27. Harrison ML, Jameson C and Gore ME: Mucinous ovarian cancer. Int J Gynecol Cancer 18: 209-214, 2008. (Pubitemid 351365218)
28. Winter WE III, Maxwell GL, Tian C, et al: Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25: 3621-3627, 2007. (Pubitemid 47372600)
29. Fujiu K, Miyamoto H, Hashimoto S, et al: A case of diaphragmatic clear cell carcinoma in a patient with a medical history of ovarian endometriosis. Int J Clin Oncol 15: 489-492, 2010.
30. Silva EG, Robey-Cafferty SS, Smith TL and Gershenson DM: Ovarian carcinomas with transitional cell carcinoma pattern. Am J Clin Pathol 93: 457-465, 1990. (Pubitemid 20128839)